BSECompany Update2d ago · 10 Aug 2026, 06:38 pm
Pursuant to Regulation 32(6) of SEBI (LODR) Regulations 2015, read with Regulation 173A of SEBI (ICDR) Regulations, 2018, please find enclosed Monitoring Agency Report towards utilisation ....
Wockhardt Ltd · 532300
✦ AI SummaryResults
Wockhardt Ltd has submitted a Monitoring Agency Report for the quarter ended June 30, 2026, regarding the utilization of proceeds from its Qualified Institutional Placement (QIP) in November 2024. The report confirms that there has been no deviation in the utilization of issue proceeds from the objects as stated in the Placement Document.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Wockhardt Ltd - 532300 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Attachments (1)
📄pdf
Download →
5bba33d1-85fc-48d0-811f-db703758cfd4.pdf
View document text
Ref. No.: WOCK/SEC/SE/2026-27/033 August 10, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relations Department Exchange Plaza
P J Towers, Dalal Street Bandra Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai - 400 051
Scrip Code: 532300 NSE Symbol: WOCKPHARMA
Sub: Monitoring Agency Report for the quarter ended June 30, 2026
Dear Sir/Madam,
Pursuant to Regulation 32(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, read with Regulation 173A of the SEBI (Issue of Capital and Disclosure Requirements)
Regulations, 2018, please find enclosed Monitoring Agency Report towards utilization of proceeds of
Qualified Institutions Placement (“QIP”) for the quarter ended June 30, 2026, issued by CRISIL Ratings
Limited, duly reviewed and taken on record by the Board of Directors & Audit Committee of the Company.
Further, we hereby confirm that there has been no deviation in the utilization of Issue proceeds from the
objects as stated in the Placement Document dated November 11, 2024.
Kindly take the above information on record.
Thanking you,
For Wockhardt Limited
Rashmi Mamtura
Company Secretary
Monitoring Agency Report
Wockhardt Limited
for the quarter ended
June 30, 2026
CRL/MAR/WOCLIM/2026-27/1972
August 10, 2026
Wockhardt Limited
Wockhardt Research Centre,
D – 4, MIDC, Chikalthana,
Aurangabad 431 006,
Maharashtra, India
Dear Sir,
Monitoring Agency Report for the quarter ended June 30, 2026 - in relation to the Qualified Institutional
Placement (“QIP”) of Wockhardt Limited (“the Company”)
Pursuant to Regulation 173A of SEBI (lssue of Capital and Disclosure Requirements) Regulations, 2018 (“SEBI
ICDR Regulations”) and Monitoring Agency Agreement dated October 28, 2024, enclosed herewith the Monitoring
Agency Report, issued by Crisil Ratings Limited, Monitoring Agency, as per Schedule XI of the SEBI ICDR
Regulations towards utilization of proceeds of QIP for the quarter ended June 30, 2026.
Request you to kindly take the same on records.
Thanking you,
For and on behalf of Crisil Ratings Limited
Shounak Chakravarty
Director, Ratings (LCG)
Report of the Monitoring Agency (MA)
Name of the issuer: Wockhardt Limited
For quarter ended: June 30, 2026
Name of the Monitoring Agency: Crisil Ratings Limited
(a) Deviation from the objects: No
(b) Range of Deviation: Not applicable
Declaration:
We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the
issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and
reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/
statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no
responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do
not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this
report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the
agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the
Companies Act, 2013.
The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains
and may receive separate compensation for its ratings and certain credit-related analyses. We confirm that we do not perceive
any conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the
issuer.
We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable.
There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the
Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer
and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA
takes no responsibility for such comments of the issuer’s Management/Board.
Signature:
Name and designation of the Authorized Signatory: Shounak Chakravarty
Designation of Authorized person/Signing Authority: Director, Ratings (LCG)
1) Issuer Details:
Name of the issuer: Wockhardt Limited
Names of the promoter: a. Mr. Habil F Khorakiwala
b. Themisto Trustee Company Private Limited
Industry/sector to which it belongs: Pharmaceuticals
2) Issue Details
Issue Period: November 06, 2024, to November 11, 2024
Type of issue (public/rights): Qualified Institutional Placement (QIP)
Type of specified securities: Equity Shares
QIP Grading, if any: NA
Issue size: Gross proceeds: Rs 1,000.00 crores
Net proceeds: Rs 977.79 crores*#
*Crisil Ratings shall be monitoring the net proceeds.
# During the quarter ended June 30, 2025, net proceeds have been revised from Rs 973.97 crores to Rs 977.79 crores, on
account of actual issue expenses being lower than estimated as disclosed in the Offer Document, by Rs 3.82 crores and the
same has been adjusted with Object 3: General Corporate Purposes.
3) Details of the arrangement made to ensure the monitoring of issue proceeds:
Source of information/
certifications Comments of Comments
considered by the of the
Particulars Reply
Monitoring Agency Monitoring Board of
for preparation of Agency Directors
report
Management
undertaking, Peer
Reviewed Independent
Whether all utilization is as per the disclosures No
Yes Chartered Accountant No Comments
in the Offer Document? Comments
Certificate^, Placement
Document, Bank
Statements
Whether shareholder approval has been
obtained in case of material deviations from No
NA No Comments
expenditures disclosed in the Offer Comments
Document?
Whether the means of finance for the disclosed No
No No Comments
objects of the issue has changed? Comments
Source of information/
certifications Comments of Comments
considered by the of the
Particulars Reply
Monitoring Agency Monitoring Board of
for preparation of Agency Directors
report
Is there any major deviation observed over the No
NA No Comments
earlier monitoring agency reports? Comments
Whether all Government/statutory approvals No
NA No Comments
related to the object(s) have been obtained? Comments
Management
Undertaking*
Whether all arrangements pertaining to
technical assistance/collaboration are in NA No Comments
Comments
operation?
Are there any favorable events improving the No
No No Comments
viability of these object(s)? Comments
Are there any unfavorable events affecting the No
No No Comments
viability of the object(s)? Comments
Is there any other relevant information that
may materially affect the decision making of No No Comments
Comments
the investors?
NA represents Not Applicable
^Certificate dated August 05, 2026, issued by M/s Harshil Patel & Co., Chartered Accountants (Firm Registration Number:
148237W), Peer-reviewed Independent Chartered Accountant.
*The Monitoring Agency has relied solely on the management undertaking as the Peer Reviewed Independent Chartered
Accountant has not expressed an opinion on these.
4) Details of object(s) to be monitored:
i. Cost of the object(s):
Source of Original Comments of the Board of Directors
information/ cost
Revised Comment of Particulars
certification (as per the
Sr. Cost the Reason of Proposed of firm
Item considered by Offer
No. (Rs in Monitoring Cost financing arrangement
Head MA for Document)
crore) agency revision option s
preparation of (Rs in
made
report crore)
Repayment and /
or pre – payment,
in full or part, of
1 500.00 500.00 No revision No Comments
certain borrowings
availed by the
Company
Management
undertaking,
Independent
Funding of capital
Chartered
expenditure,
Account
[Showing first 8,000 characters — download PDF for full document]